Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.


KISACIK B., PAMUK Ö. N. , ONAT A. M. , ERER S. B. , HATEMİ G., ÖZGÜLER Y., ...More

ACR/ARHP 2014, BOSTON, United States Of America, 14 - 19 November 2014, vol.66, pp.943-944 identifier

  • Publication Type: Conference Paper / Full Text
  • Volume: 66
  • City: BOSTON
  • Country: United States Of America
  • Page Numbers: pp.943-944